| Cash Flow | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-10-31 |
|---|---|---|---|---|
| Revenue | - | 139,651 | 66,265 | - |
| Cost of revenue | - | 39,741 | 19,151 | - |
| Research and development expense | - | 35,751 | 17,376 | - |
| Sales and marketing | - | 29,719 | 14,287 | - |
| General and administrative | - | 26,834 | 14,252 | - |
| Depreciation and amortization | - | 21,704 | 11,082 | - |
| Stock-based compensation | - | 25,998 | 12,542 | - |
| Restructuring costs | - | 20 | 20 | - |
| Certain litigation expenses | - | 615 | 326 | - |
| Other segment items | - | -5,511 | -10,143 | - |
| Consolidated net loss | -94,405 | -35,220 | -12,628 | -88,042 |
| Depreciation and amortization | 31,612 | 21,704 | 11,082 | 36,365 |
| Stock-based compensation, net of capitalized cost of 1,892 and 1,793, respectively | 39,471 | 25,998 | 12,542 | 36,467 |
| Change in fair value of warrant liabilities | 38,765 | -4,708 | -10,387 | -1,126 |
| Change in fair value of contingent consideration | 2,071 | 676 | -41 | 3,161 |
| Other | 1,772 | 1,538 | 1,229 | -932 |
| Accounts receivable | -7,344 | -2,363 | 21,185 | -5,487 |
| Prepaid expenses and other assets | -1,052 | -272 | -1,254 | -8,499 |
| Accounts payable, accrued and other liabilities | -10,320 | -4,342 | -8,915 | -7,731 |
| Deferred revenue | 96,623 | 75,813 | 42,072 | 71 |
| Deferred hosting costs | -272 | 1,026 | 2,323 | -298 |
| Net cash provided by (used in) operating activities | 113,713 | 85,120 | 17,346 | -8,079 |
| Purchases of property and equipment | 55,114 | 28,410 | 8,119 | 32,694 |
| Capitalized internal-use software | 3,398 | 2,420 | 1,225 | 4,145 |
| Maturities of available-for-sale securities | 45,017 | 27,131 | 11,123 | 57,046 |
| Sales of available-for-sale securities | 33,079 | 9,254 | 582 | 162,341 |
| Purchases of available-for-sale securities | 207,138 | 22,361 | 0 | 105,582 |
| Business acquisition, net of cash acquired | 0 | 0 | 0 | 1,068 |
| Purchases of licensed imagery intangible assets | 1,153 | 892 | 621 | 4,558 |
| Other | 0 | 0 | 0 | 300 |
| Net cash provided by (used in) investing activities | -188,707 | -17,698 | 1,740 | 71,040 |
| Proceeds from the exercise of common stock options | 19,932 | 8,451 | 2,962 | 332 |
| Payments for withholding taxes related to the net share settlement of equity awards | 28,319 | 12,436 | 5,264 | 7,328 |
| Proceeds from employee stock purchase program | 1,851 | 1,163 | 346 | 1,083 |
| Payments of contingent consideration for business acquisitions | 4,047 | 4,820 | 4,820 | 8,783 |
| Payment of indemnification holdback for business acquisition | 5,000 | - | - | - |
| Proceeds from issuance of convertible notes, net of discount | 448,759 | - | - | - |
| Payment of debt issuance costs | 2,929 | - | - | - |
| Proceeds from the exercise of warrants | 64 | - | - | - |
| Purchase of capped call transactions | 39,560 | - | - | - |
| Other | -2,659 | -2,521 | -2,383 | -606 |
| Net cash provided by (used in) financing activities | 388,092 | -10,163 | -9,159 | -15,302 |
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | 6,530 | 5,677 | 5,683 | 74 |
| Net increase in cash and cash equivalents, and restricted cash and cash equivalents | 319,628 | 62,936 | 15,610 | 47,733 |
| Cash and cash equivalents at beginning of period | 129,994 | 129,994 | 129,994 | 102,198 |
| Cash and cash equivalents at end of period | 449,622 | 192,930 | 145,604 | 149,931 |
Planet Labs PBC (PL-WT)
Planet Labs PBC (PL-WT)